Search

Author/Creator Pandey, Santosh Kumar

1. 0120 SUVN-G3031, a Novel, Potent and Selective Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy: Preclinical Characterization. (12th April 2019)

Authors:
Bhayrapuneni, Gopinadh; Kamuju, Venkatesh; Gandipudi, Sudhakar; Jayarajan, Pradeep; Abraham, Renny; Bojja, Kumar; Pandey, Santosh Kumar; Mekala, Venkat Reddy; Nirogi, Ramakrishna
Journal:
Sleep
Issue:
Volume 42(2019)Supplement 1
Page Start:
A50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 0139 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Phase-2 Investigational New Drug for the Treatment of Narcolepsy - Differentiating Factors with Competitor Clinical Candidates. (12th April 2019)

Authors:
Nirogi, Ramakrishna; Bhyrapuneni, Gopinadh; Abraham, Renny; Subramanian, Ramkumar; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Badange, Rajesh; Shinde, Anil
Journal:
Sleep
Issue:
Volume 42(2019)Supplement 1
Page Start:
A57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 0265 Samelisant (SUVN-G3031), a Histamine H3 Receptor Inverse Agonist in Animal Models of Narcolepsy. (25th May 2022)

Authors:
Benade, Vijay; Abraham, Renny; Palacharla, Raghava Chowdary; Thentu, Jagadeesh Babu; Petlu, Surendra; Mekala, Venkat Reddy; Pandey, Santosh Kumar; Badange, Rajesh Kumar; Bojja, Kumar; Reballi, Veena; Achanta, Pramod Kumar; Choudakari, Praveen kumar; Nirogi, Ramakrishna
Journal:
Sleep
Issue:
Volume 45(2022)Supplement 1
Page Start:
A119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. [P1–063]: SUVN‐G3031, A SELECTIVE H3 RECEPTOR INVERSE AGONIST: ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS. (1st July 2017)

Authors:
Muddana, NageswaraRao; Bhyrapuneni, Gopinadh; Mudigonda, Koteshwara; Jayarajan, Pradeep; Abraham, Renny; Subramanian, Ramkumar; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Boggavarapu, Rajesh Kumar; Ajjala, Devender Reddy; Shinde, Anil K.; Nirogi, Ramakrishna
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. [P1–460]: SUVN‐D4010: A POTENT AND SELECTIVE 5‐HT4 RECEPTOR PARTIAL AGONIST— ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS. (1st July 2017)

Authors:
Bhyrapuneni, Gopinadh; Mudigonda, Koteshwara; Chowdary Palacharla, Veera Raghava; Jayarajan, Pradeep; Abraham, Renny; Subramanian, Ramkumar; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Boggavarapu, Rajesh Kumar; Ajjala, Devender Reddy; Rasheed, Mohammed Abdul; Nirogi, Ramakrishna
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 9
Page Start:
P463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. [P2–033]: SUVN‐502 + DONEPEZIL + MEMANTINE (TRIPLE COMBINATION) REPRESENTS A PROMISING NEW APPROACH FOR SYMPTOMATIC TREATMENT OF ALZHEIMER's DISEASE. (1st July 2017)

Authors:
Nirogi, Ramakrishna; Mudigonda, Koteshwara; Ravulu, Jyothsna; Bhyrapuneni, Gopinadh; Benade, Vijay; Muddana, Nageswara Rao; Chowdary Palacharla, Veera Raghava; Ajjala, Devender Reddy; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Abraham, Renny; Jayarajan, Pradeep; Kambhampati, Ramasastry; Shinde, A...
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 12
Page Start:
P617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗